WASHINGTON >> The nation’s three largest pharmacy benefit managers have significantly marked up the prices of certain ...

Optum RX, CVS Caremark and Express Scripts are marking up drugs that treat cancer and multiple sclerosis by more than ...

The report is the latest indictment of America’s broken healthcare system.

From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 ...

The FTC study examines the practices of PBMs to ensure fair competition and transparency. The FTC found that from 2017 to 2022, the three big PBMs imposed substantial price markups on 51 specialty ...

The U.S. Federal Trade Commission on Tuesday published the second part of its investigation into how prescription drug ...

The U.S. Federal Trade Commission (FTC) has slammed pharmacy benefit managers (PBMs) owned by UnitedHealth ($UNH), CVS Health ...

CVS Health Corporation is a vertically integrated healthcare corporation in the United States. The company owns a leading ...

Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from "excess" ...

The new document focuses on the influence of PBMs over the market for specialty generic drugs for illnesses like cancer, ...

Bernstein analyst Lance Wilkes maintained a Hold rating on CVS Health (CVS – Research Report) yesterday and set a price target of $52.00. The ...

The nation’s three largest PBMs – CVS Health’s Caremark, Cigna’s Express Scripts and UnitedHealth Group’s Optum Rx – inflated ...